• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
OLMA

OLMA

Olema Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD10.51

-0.18 (-1.68%)

Rating:C+

Company Profile

CEO

Sean Bohen

IPO Date

2020-11-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.66

Prev. Close

$10.69

Day Low

$10.32

Day High

$11.01

52W Low

$3.89

52W High

$36.26

Market Cap

$0.92B

Volume

1.39M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

7

Avg Positive

10.0%

Avg Negative

1.4%

Avg Neutral

88.6%

News Feed

Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference

GlobeNewsWire·5/18/2021·↑ positive

Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors

GlobeNewsWire·4/6/2021·↑ positive

Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates

GlobeNewsWire
·3/17/2021
·↑ positive

Olema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021

GlobeNewsWire·3/10/2021·↑ positive

Olema Oncology Announces Two Poster Presentations at the San Antonio Breast Cancer Symposium 2020

GlobeNewsWire·12/7/2020·↑ positive

Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·11/23/2020·↑ positive

Olema Oncology Announces Pricing of Initial Public Offering

GlobeNewsWire·11/18/2020·↑ positive